PL403149A1 - Nowe związki pochodne pirazolilobenzo[d]imidazolu - Google Patents

Nowe związki pochodne pirazolilobenzo[d]imidazolu

Info

Publication number
PL403149A1
PL403149A1 PL403149A PL40314913A PL403149A1 PL 403149 A1 PL403149 A1 PL 403149A1 PL 403149 A PL403149 A PL 403149A PL 40314913 A PL40314913 A PL 40314913A PL 403149 A1 PL403149 A1 PL 403149A1
Authority
PL
Poland
Prior art keywords
pirazolilobenzo
new
imidazole derivatives
absent
compounds
Prior art date
Application number
PL403149A
Other languages
English (en)
Inventor
Daria Zdżalik
Joanna Lipner
Maciej Wieczorek
Karolina Dzwonek
Abdellah Yamani
Krzysztof Dubiel
Monika Lamparska-Przybysz
Original Assignee
Celon Pharma Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celon Pharma Spółka Akcyjna filed Critical Celon Pharma Spółka Akcyjna
Priority to PL403149A priority Critical patent/PL403149A1/pl
Priority to HRP20170190TT priority patent/HRP20170190T1/hr
Priority to SI201430168A priority patent/SI2970210T1/sl
Priority to BR112015023092-0A priority patent/BR112015023092B1/pt
Priority to CA2900629A priority patent/CA2900629C/en
Priority to HUE14712781A priority patent/HUE031368T2/en
Priority to AU2014229401A priority patent/AU2014229401B2/en
Priority to MX2015012346A priority patent/MX364172B/es
Priority to PL14712781T priority patent/PL2970210T3/pl
Priority to US14/775,240 priority patent/US9776988B2/en
Priority to KR1020157027305A priority patent/KR102266546B1/ko
Priority to JP2015562456A priority patent/JP6594779B2/ja
Priority to CN201480008829.4A priority patent/CN105008348B/zh
Priority to EA201591617A priority patent/EA026782B1/ru
Priority to PT147127815T priority patent/PT2970210T/pt
Priority to ES14712781.5T priority patent/ES2622376T3/es
Priority to PCT/IB2014/059515 priority patent/WO2014141015A1/en
Priority to DK14712781.5T priority patent/DK2970210T3/en
Priority to EP14712781.5A priority patent/EP2970210B1/en
Publication of PL403149A1 publication Critical patent/PL403149A1/pl
Priority to IL241234A priority patent/IL241234A0/en
Priority to ZA2015/07548A priority patent/ZA201507548B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Związki będące przedmiotem wynalazku są przedstawione wzorem ogólnym (I), w którym atom wodoru przy pierścieniach pirazolowym i benzimidazolowym jest przyłączony do jednego z atomów azotu pierścienia; R1 oznacza -X-Q-P, gdzie X jest nieobecny lub oznacza -CH2-, -C(O)-, -C(O)NH-(CH2)k-, gdzie k jest 0, 1 lub 2; Q jest wybrany z grupy składającej się z grup Q1, Q2, Q3, Q4 i Q5, które mają znaczenia podane w opisie, przy czym gdy B w Q1 oznacza atom tlenu, to P jest nieobecny; oraz ich sole addycyjne z kwasami. Związki wykazują działanie jako inhibitory kinazy FGFR i mogą znaleźć zastosowanie w leczeniu chorób nowotworowych.
PL403149A 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu PL403149A1 (pl)

Priority Applications (21)

Application Number Priority Date Filing Date Title
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu
US14/775,240 US9776988B2 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives
CN201480008829.4A CN105008348B (zh) 2013-03-14 2014-03-07 吡唑基苯并[d]咪唑衍生物
BR112015023092-0A BR112015023092B1 (pt) 2013-03-14 2014-03-07 Derivados de pirazolilbenzo[ d] imidazóis
CA2900629A CA2900629C (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives
HUE14712781A HUE031368T2 (en) 2013-03-14 2014-03-07 Pirazolilbenzo [d] imidazole derivatives
AU2014229401A AU2014229401B2 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives
MX2015012346A MX364172B (es) 2013-03-14 2014-03-07 Derivados de pirazolilbenzo[d]imidazol.
PL14712781T PL2970210T3 (pl) 2013-03-14 2014-03-07 Pochodne pirazolilobenzo[d]imidazolu
HRP20170190TT HRP20170190T1 (hr) 2013-03-14 2014-03-07 Derivati pirazolilbenzo[d]imidazola
KR1020157027305A KR102266546B1 (ko) 2013-03-14 2014-03-07 피라졸릴벤조[d]이미다졸 유도체
JP2015562456A JP6594779B2 (ja) 2013-03-14 2014-03-07 ピラゾリルベンゾ［ｄ］イミダゾール誘導体
SI201430168A SI2970210T1 (sl) 2013-03-14 2014-03-07 Pirazolilbenzo(d)imidazolni derivati
EA201591617A EA026782B1 (ru) 2013-03-14 2014-03-07 ПРОИЗВОДНЫЕ ПИРАЗОЛИЛБЕНЗО[d]ИМИДАЗОЛА
PT147127815T PT2970210T (pt) 2013-03-14 2014-03-07 Derivados de pirazolilbenzo[d]imidazole
ES14712781.5T ES2622376T3 (es) 2013-03-14 2014-03-07 Derivados de pirazolilbenzo[d]imidazol
PCT/IB2014/059515 WO2014141015A1 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives
DK14712781.5T DK2970210T3 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo [d] imidazole
EP14712781.5A EP2970210B1 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives
IL241234A IL241234A0 (en) 2013-03-14 2015-09-07 History of pyrazolylbenzo[d]imidazole derivatives
ZA2015/07548A ZA201507548B (en) 2013-03-14 2015-10-12 Pyrazolylbenzo[d]imidazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu

Publications (1)

Publication Number Publication Date
PL403149A1 true PL403149A1 (pl) 2014-09-15

Family

ID=50382512

Family Applications (2)

Application Number Title Priority Date Filing Date
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu
PL14712781T PL2970210T3 (pl) 2013-03-14 2014-03-07 Pochodne pirazolilobenzo[d]imidazolu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14712781T PL2970210T3 (pl) 2013-03-14 2014-03-07 Pochodne pirazolilobenzo[d]imidazolu

Country Status (20)

Country Link
US (1) US9776988B2 (pl)
EP (1) EP2970210B1 (pl)
JP (1) JP6594779B2 (pl)
KR (1) KR102266546B1 (pl)
CN (1) CN105008348B (pl)
AU (1) AU2014229401B2 (pl)
BR (1) BR112015023092B1 (pl)
CA (1) CA2900629C (pl)
DK (1) DK2970210T3 (pl)
EA (1) EA026782B1 (pl)
ES (1) ES2622376T3 (pl)
HR (1) HRP20170190T1 (pl)
HU (1) HUE031368T2 (pl)
IL (1) IL241234A0 (pl)
MX (1) MX364172B (pl)
PL (2) PL403149A1 (pl)
PT (1) PT2970210T (pl)
SI (1) SI2970210T1 (pl)
WO (1) WO2014141015A1 (pl)
ZA (1) ZA201507548B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3296297A1 (en) * 2016-09-15 2018-03-21 Centre National De La Recherche Scientifique Benzimidazol derivatives for treating filovirus infection
CN107698538B (zh) * 2016-11-30 2020-02-14 内蒙古京东药业有限公司 罗沙替丁醋酸酯盐酸盐的中间体3-(1-哌啶甲基)苯酚的制备方法
CN107163030B (zh) * 2017-06-20 2020-03-24 河南工业大学 具有吡唑母核的小分子杂环化合物及其用于制备抗菌、抗肿瘤药物的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200433B1 (en) 1999-08-02 2006-03-22 Ortho-McNeil Pharmaceutical, Inc. C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
US6897208B2 (en) 2001-10-26 2005-05-24 Aventis Pharmaceuticals Inc. Benzimidazoles
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
WO2006033943A2 (en) * 2004-09-17 2006-03-30 Exelixis, Inc Pyrazole kinase modulators and methods of use
MX2007008008A (es) 2004-12-30 2007-11-12 Astex Therapeutics Ltd Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora.
JP5474354B2 (ja) * 2005-12-30 2014-04-16 アステックス、セラピューティックス、リミテッド 医薬化合物
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
CA2728063A1 (en) * 2008-06-19 2009-12-23 Astrazeneca Ab Pyrazole compounds 436
US8729102B2 (en) * 2010-11-30 2014-05-20 Takeda Pharmaceutical Company Limited Bicyclic compound
RS56748B1 (sr) * 2011-05-13 2018-03-30 Glaxosmithkline Biologicals Sa Pre-fuzioni rsv f antigeni

Also Published As

Publication number Publication date
WO2014141015A1 (en) 2014-09-18
BR112015023092B1 (pt) 2021-11-16
CA2900629A1 (en) 2014-09-18
MX364172B (es) 2019-04-15
CN105008348B (zh) 2018-07-10
AU2014229401A1 (en) 2015-08-20
KR102266546B1 (ko) 2021-06-21
ZA201507548B (en) 2017-02-22
EP2970210A1 (en) 2016-01-20
US20160039794A1 (en) 2016-02-11
DK2970210T3 (en) 2017-04-10
PT2970210T (pt) 2017-04-07
KR20150126893A (ko) 2015-11-13
AU2014229401B2 (en) 2018-05-17
JP6594779B2 (ja) 2019-10-23
EA026782B1 (ru) 2017-05-31
EP2970210B1 (en) 2017-01-04
EA201591617A1 (ru) 2016-01-29
BR112015023092A2 (pt) 2017-07-18
MX2015012346A (es) 2016-02-03
JP2016516024A (ja) 2016-06-02
IL241234A0 (en) 2015-11-30
HUE031368T2 (en) 2017-07-28
CA2900629C (en) 2020-12-15
HRP20170190T1 (hr) 2017-04-07
US9776988B2 (en) 2017-10-03
ES2622376T3 (es) 2017-07-06
PL2970210T3 (pl) 2017-09-29
CN105008348A (zh) 2015-10-28
SI2970210T1 (sl) 2017-05-31

Similar Documents

Publication Publication Date Title
MX383051B (es) Compuestos que inhiben eif4a y métodos relacionados a los mismos.
ECSP109965A (es) Imidazoles fusionados para el tratamiento del cancer
PE20160115A1 (es) Compuestos derivados de imidazol como inhibidores de protein quinasa
CR20200376A (es) Inhibidores de cd73
MX2020011558A (es) Imidazolonilquinolinas y el uso de las mismas como inhibidores de cinasa atm.
GEP201706691B (en) Substituted phthalazin-1 (2h)-one derivatives as selecti- ve inhibitors of poly (adp-ribose) polymerase-1
CR20190423A (es) Nuevos compuestos biciclícos como inhibidores dobles de atx/ca
MX2020009887A (es) Derivados de aminopiridina como inhibidores de ctps1.
MA44820A1 (fr) Amides hétérocycliques a utiliser en tant qu'inhibiteurs de kinase
MX2018010025A (es) Derivados de quinazolindion-6-carbonilo y su utilizacion como herbicidas.
EA201790595A1 (ru) Пиримидиноны в качестве ингибиторов фактора xia
UA111382C2 (uk) Інгібітори протеїнкінази
UY35898A (es) ?compuestos inhibidores de syk y composiciones que los comprenden?.
JO3261B1 (ar) مشتق بيريدين أحادي الحلقة
CO7111292A2 (es) Derivados cíclicos de diaminopirimidina
EA201992320A1 (ru) Пиперидины в качестве ковалентных ингибиторов менина
EA201391239A1 (ru) Пирроло[2,3-d]пиримидиновые производные в качестве ингибиторов тропомиозин-связанных киназ
MX371353B (es) Compuestos heterociclicos aromaticos como compuestos antiinflamatorios.
EA201790779A1 (ru) Замещенные аминопуриновые соединения, их композиции и способы лечения с использованием таких соединений
UA107784C2 (en) Inhibitor of melanin production
EA201591301A1 (ru) Новые пиримидиновые и пиридиновые соединения и их применение
WO2017087808A8 (en) Heterocyclic compounds that inhibit the kinase activity of mnk useful for treating various cancers
EA201200875A1 (ru) Ингибиторы сфингозинкиназы
MX2018008362A (es) Derivados de quinolin-2-ona.
EA201600403A1 (ru) N-ацилиминогетероциклические соединения